TFL Gallery / t-populations

t-populations

Discovered on disk but not present in site/config.json.

This display exists on disk but is not registered in site/config.json, so it has no reviewed metadata.

Slug
t-populations
Regulatory ID
Type
Table
E3 position
unassigned
Status
built
Current iteration
v002
Datasets
Evidence
not yet generated
Requirements
Used in

Generated by the same pipeline run that wrote the ARD and the HTML above, from the same rendered cells; the short hash is the manifest's record of the file.

t-populations · post_text variant · study CDISCPILOT01 · data cut-off 2015-03-05

Summary of Populations
Study CDISCPILOT01 — All Subjects
Placebo (N=86) Xanomeline Low Dose (N=84) Xanomeline High Dose (N=84) Total (N=254)
Intent-To-Treat (ITT) 86 (100%) 84 (100%) 84 (100%) 254 (100%)
Safety 86 (100%) 84 (100%) 84 (100%) 254 (100%)
Efficacy 79 (92%) 81 (96%) 74 (88%) 234 (92%)
Complete Week 24 60 (70%) 28 (33%) 30 (36%) 118 (46%)
Complete Study 58 (67%) 25 (30%) 27 (32%) 110 (43%)
N in the column headers is the number of subjects randomised to that treatment group; percentages are based on it. The reference report's note calls this the number of subjects "entered in study (i.e., signed informed consent)". This display does not repeat that wording: 306 subjects were screened and 254 randomised, and it is the 254 that N counts.
The ITT population includes all subjects randomised. The Safety population includes all randomised subjects known to have taken at least one dose of randomised study drug. The Efficacy population includes all subjects in the safety population who also have at least one post-baseline ADAS-Cog and CIBIC+ assessment.
Treatment groups are planned (randomised) treatment, TRT01P. In this ADSL planned and actual treatment agree for all 254 subjects.
The population line above reads All Subjects because that is what the reference report prints above this table. In this study it selects the same 254 subjects as the Intent-To-Treat row below, since the analysis dataset contains only randomised subjects and every one of them carries ITTFL = Y.
Complete Week 24 is the study's own COMP24FL. Complete Study is not a variable the study ships: the reference report prints the row but states no definition for it, so this display derives it as the complement of the study's own DISCONFL — a subject who did not discontinue. That derivation is open.csr's, not the study's, and the evidence for it is that it reproduces all four printed figures (58, 25, 27, 110) and the report's own narrative that 110 subjects completed the study through Week 26.
The cut-off shown is the latest subject end date (RFENDT) recorded in the vendored ADSL. The CDISC pilot package states no separate database-lock date.
Source: adsl (phuse-org/phuse-scripts, data/adam/cdisc — the CDISC pilot submission's own ADaM package). Data cut-off: 2015-03-05.
open.csr display t-populations (post_text variant); generated from the committed ARD.

Rendered from outputs/t-populations/v002/table.html.

Every iteration is kept: outputs/t-populations/vNNN/ holds the spec snapshot, the ARD, the rendered output, and a manifest recording who regenerated it, why, and from which commit.